Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance, beginning of period at Dec. 31, 2018 $ 5,129 $ 15 $ 148,641 $ (143,527)
Balance, shares at Dec. 31, 2018   15,591,357    
Beginning balance adjustment – impact of ASC 606 | ASC 606 3,115     3,115
Issuance of common stock, net of issuance costs 1,604 $ 1 1,603  
Issuance of common stock, net of issuance costs, shares   227,628    
Issuance of common stock upon exercise of stock options 41   41  
Issuance of common stock upon exercise of stock options, shares   54,720    
Employee and nonemployee stock-based compensation 47   47  
Net loss (5,124)     (5,124)
Balance, at end of period at Mar. 31, 2019 4,812 $ 16 150,332 (145,536)
Balance, shares at Mar. 31, 2019   15,873,705    
Balance, beginning of period at Dec. 31, 2018 5,129 $ 15 148,641 (143,527)
Balance, shares at Dec. 31, 2018   15,591,357    
Balance, at end of period at Dec. 31, 2019 25,525 $ 20 191,751 (166,246)
Balance, shares at Dec. 31, 2019   20,437,235    
Issuance of common stock upon exercise of stock options $ 210 $ 1 209  
Issuance of common stock upon exercise of stock options, shares 240,125 240,125    
Employee and nonemployee stock-based compensation $ 223   223  
Net loss (9,964)     (9,964)
Balance, at end of period at Mar. 31, 2020 $ 15,994 $ 21 $ 192,183 $ (176,210)
Balance, shares at Mar. 31, 2020   20,677,360